Filipinler - İngilizce - FDA (Food And Drug Administration)

baxter healthcare phils inc - dobutamine hydrochloride 5% dextrose - solution for injection iv - 2mg/ml (200mcg/ml)

ABD - İngilizce - NLM (National Library of Medicine)

hospira, inc. - dopamine hydrochloride (unii: 7l3e358n9l) (dopamine - unii:vtd58h1z2x) - dopamine hydrochloride 0.8 mg in 1 ml - dopamine hydrochloride in dextrose injection is indicated to improve hemodynamic status in patients in distributive shock, or shock due to reduced cardiac output. dopamine is contraindicated in patients with pheochromocytoma. risk summary there are no human data with dopamine use in pregnant women. there are risks to the mother and fetus from hypotension associated with shock, which can be fatal if left untreated (see clinical considerations ). in animal reproduction studies, adverse developmental outcomes were observed with intravenous dopamine hcl administration in pregnant rats during organogenesis at dosages, on a mcg/m2 basis, of one-third the human starting dosage of 2 mcg/kg/minute (90 mcg/m2 /minute). the background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies carry some risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the background risk of major birth defects and miscarriage in clinically recognized pregna

Japonya - İngilizce - すりの適正使用協議会 RAD-AR Council, Japan

kyowa kirin co.,ltd - dobutamine hydrochloride - injection

Japonya - İngilizce - すりの適正使用協議会 RAD-AR Council, Japan

kyowa kirin co.,ltd - dobutamine hydrochloride - injection

Japonya - İngilizce - すりの適正使用協議会 RAD-AR Council, Japan

kyowa kirin co.,ltd - dobutamine hydrochloride - injection

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

hospira nz ltd - dobutamine hydrochloride 0.56 mg/ml equivalent to 0.5 mg/ml dobutamine - solution for infusion - 0.5 mg/ml - active: dobutamine hydrochloride 0.56 mg/ml equivalent to 0.5 mg/ml dobutamine excipient: disodium edetate dihydrate glucose monohydrate sodium metabisulfite water for injection

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

hospira nz ltd - dobutamine hydrochloride 2.24 mg/ml equivalent to 2.0 mg/ml dobutamine - solution for infusion - 2 mg/ml - active: dobutamine hydrochloride 2.24 mg/ml equivalent to 2.0 mg/ml dobutamine excipient: disodium edetate dihydrate glucose monohydrate sodium metabisulfite water for injection

ABD - İngilizce - NLM (National Library of Medicine)

baxter healthcare corporation - dopamine hydrochloride (unii: 7l3e358n9l) (dopamine - unii:vtd58h1z2x) - dopamine hydrochloride 80 mg in 100 ml - dopamine hydrochloride is indicated for the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarctions, trauma, endotoxic septicemia, open heart surgery, renal failure and chronic cardiac decompensation as in congestive failure. where appropriate, restoration of blood volume with a suitable plasma expander or whole blood should be instituted or completed prior to administration of dopamine hydrochloride. patients most likely to respond adequately to dopamine hydrochloride are those in whom physiological parameters, such as urine flow, myocardial function and blood pressure have not undergone profound deterioration. reports indicate that the shorter the time interval between onset of signs and symptoms and initiation of therapy with volume correction and dopamine hydrochloride, the better the prognosis. urine flow appears to be one of the better diagnostic signs by which adequacy of vital organ perfusion can be monitored. nevertheless, the physician should also observe the

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - dobutamine hydrochloride - concentrate for soln for inf - 12.5 mg/ml

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - dobutamine - concentrate for solution for infusion - 12.5 milligram(s)/millilitre - adrenergic and dopaminergic agents; dobutamine